Back to Newsroom

Corbus Pharmaceuticals to Host Research and Development Day on March 13, 2017

Updates on clinical development of JBT-101 and presentation of new pre-clinical and MOA data; Live video webcast on March 13th from 11:00 AM to 1:00 PM ET

NORWOOD, MA — (Marketwired) — 02/21/17 — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, today announced that it will host its inaugural Research and Development (R&D) Day event for the institutional investment community in New York City on Monday, March 13, 2017. The formal program and video webcast will begin at 11:00 AM and will conclude at 1:00 PM.

Click here to read the full release